From: Rhabdomyolysis in older adults: outcomes and prognostic factors
Data at inclusion | Total (n = 343) | Missing data | |
---|---|---|---|
Gender | Female, N (%) | 155 (45.2) | 0 |
Age (years) | Mean (SD) | 68.7 (20.2) | 0 |
Rural / Urban | Rural, N (%) | 64 (18.7) | 0 |
Home help | Yes, N (%) | 138 (40.2) | 3 |
Charlson | Mean (SD) | 1.3 (1.7) | 1 |
Number of medications | Mean (SD) | 4.7 (3.5) | 9 |
qSOFA ≥ 2 | Yes, N (%) | 30 (8.8) | 1 |
Etiology | Drop, N (%) Drug abuse, N (%) Muscular, N (%) Toxic, N (%) Other, N (%) | 223 (65.2) 10 (2.9) 80 (23.3) 22 (6.4) 7 (2.0) | 1 |
Initial CK (IU/L) | Median (25-75%) | 2,584 (1,372-6,629) | 0 |
Initial creatinine (µmol/L) | Median (25-75%) | 83 (65–124) | 2 |
Potassium (mmol/L) | Median (25-75%) | 4.0 (3.7–4.5) | 5 |
Hemoglobin (g/dl) | Median (25-75%) | 13.3 (12.2–14.4) | 5 |
Hematocrit (%) | Median (25-75%) | 40.0 (36.5–43.4) | 5 |
Platelets (G/L) | Median (25-75%) | 220.5 (161–274) | 5 |
Leukocytes (G/L) | Median (25-75%) | 11.8 (9.0-14.7) | 7 |
Calcium (mmol/L) | Median (25-75%) | 2.2 (2.1–2.4) | 150 |
Phosphorus (mmol/L) | Median (25-75%) | 1.0 (0.8–1.3) | 174 |
pH | Median (25-75%) | 7.4 (7.3–7.5) | 260 |
Bicarbonates (mmol/L) | Median (25-75%) | 23 (20–26) | 144 |
Complications | Total N = 219 | ||
Peak CK (IU/L) | Median (25-75%) | 3,288 (1,578-8,491) | 0 |
CK > 5000 UI/L | Yes, N (%) | 86 (39.3) | 0 |
Peak creatinine (µmol/L) | Median (25-75%) | 91 (69–136) | 1 |
Acute renal failure | Yes, N (%) | 124 (56.6) | 4 |
Disseminated intravascular coagulation | Yes, N (%) | 4 (1.8) | 5 |
Compartment syndrome | Yes, N (%) | 7 (3.2) | 5 |
Delirium | Yes, N (%) | 51 (23.3) | 5 |
Treatment | |||
Infusion | No, N (%) < 1 L, N (%) 1–2 L, N (%) > 2 L, N (%) | 18 (8.2) 66 (30.1) 70 (33.5) 55 (25.1) | 6 |
Renal dialysis | N (%) | 4 (1.8) | |
Outcomes | N = 219 | ||
Release | Return home, N (%) Post Acute Care, N (%) Nursing Home, N (%) Deaths, N (%) | 156 (71.2) 35 (16.0) 5 (2.3) 25 (11.4) | 0 |
30-days hospital mortality | Yes, N (%) | 23 (10.5) | 1 |